Keynote on Longevity Innovation, Regulation, and Collaboration

This document contains the text of a keynote address delivered at an event focused on longevity innovation. The speech, delivered by a representative of the Health Sciences Authority (HSA) of Singapore, discusses the rapid advancements in longevity science and the critical role of regulation in ensuring safety and efficacy. It emphasizes the need for a collaborative approach between innovators, regulators, and other stakeholders to foster responsible development in this emerging field.

The practical implications for regulated entities are primarily informational, as the speech outlines the general direction and considerations for regulatory bodies in the context of longevity research and products. While no specific new rules or compliance obligations are detailed, the address signals HSA's engagement with this sector and suggests that companies operating in longevity innovation should be prepared for evolving regulatory expectations and the importance of proactive engagement with the authorities.